in

Gilead says it will be able to make enough remdesivir to meet global coronavirus demand in October

Gilead said it plans to produce more than 2 million treatment courses of the drug by the end of the year and anticipates being able to make “several million more” in 2021.

Nigerian Crypto Activity Has Been On the Rise Since April

GM unveils all-electric Cadillac Lyriq as its new ‘technology spearhead’